Cargando…

Proteasome inhibition reduces plasma cell and antibody secretion, but not angiotensin II-induced hypertension

INTRODUCTION: Depletion of mature B cells affords protection against experimental hypertension. However, whether B cell-mediated hypertension is dependent on differentiation into antibody-secreting cells (ASCs) remains unclear. Using the proteasome inhibitor, bortezomib, the present study tested the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Figueiredo Galvao, Hericka Bruna, Dinh, Quynh Nhu, Thomas, Jordyn M., Wassef, Flavia, Diep, Henry, Bobik, Alex, Sobey, Christopher G., Drummond, Grant R., Vinh, Antony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272792/ https://www.ncbi.nlm.nih.gov/pubmed/37332591 http://dx.doi.org/10.3389/fcvm.2023.1184982

Ejemplares similares

Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress
por: Dinh, Quynh Nhu, et al.
Publicado: (2017)

Differential Phenotypes of Tissue-Infiltrating T Cells during Angiotensin II-Induced Hypertension in Mice
por: Wei, Zihui, et al.
Publicado: (2014)

Association of constipation with increased risk of hypertension and cardiovascular events in elderly Australian patients
por: Judkins, Courtney P., et al.
Publicado: (2023)

Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
por: Dinh, Quynh N., et al.
Publicado: (2014)

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
por: Dinh, Quynh N., et al.
Publicado: (2016)

Immune Mechanisms in Vascular Disease and Stroke
por: Toh, Ban-Hock, et al.
Publicado: (2014)

Antibodies in the Pathogenesis of Hypertension
por: Chan, Christopher T., et al.
Publicado: (2014)

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

The Vascular Consequences of Metabolic Syndrome: Rodent Models, Endothelial Dysfunction, and Current Therapies
por: Tran, Vivian, et al.
Publicado: (2020)

Distinct Redox Signalling following Macrophage Activation Influences Profibrotic Activity
por: Lewis, Caitlin V., et al.
Publicado: (2019)

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
por: Camargo, Rafael L., et al.
Publicado: (2022)

α-Ketoglutarate Upregulates Collecting Duct (Pro)renin Receptor Expression, Tubular Angiotensin II Formation, and Na(+) Reabsorption During High Glucose Conditions
por: Guerrero, Aarón, et al.
Publicado: (2021)

Bacteriophages in Natural and Artificial Environments
por: Batinovic, Steven, et al.
Publicado: (2019)

Nox1 Oxidase Suppresses Influenza A Virus-Induced Lung Inflammation and Oxidative Stress
por: Selemidis, Stavros, et al.
Publicado: (2013)

The role of inflammasomes in vascular cognitive impairment
por: Poh, Luting, et al.
Publicado: (2022)

Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment
por: Rajeev, Vismitha, et al.
Publicado: (2022)

Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
por: AlSiraj, Yasir, et al.
Publicado: (2021)

Perceval valve intermediate outcomes: a systematic review and meta-analysis at 5-year follow-up
por: Jolliffe, Jarrod, et al.
Publicado: (2023)

Bim Deletion Reduces Functional Deficits Following Ischemic Stroke in Association with Modulation of Apoptosis and Inflammation
por: Glab, Jason A., et al.
Publicado: (2022)

Intermittent Fasting Attenuates Hallmark Vascular and Neuronal Pathologies in a Mouse Model of Vascular Cognitive Impairment
por: Rajeev, Vismitha, et al.
Publicado: (2022)

Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo
por: Lee, Seyoung, et al.
Publicado: (2012)

Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
por: Agostinucci, Kevin, et al.
Publicado: (2022)

SAT-562 Angiotensin II Induces Aldosterone Synthesis in the Rat Heart Stressed by Angiotensin II
por: Bose, Himangshu S, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Tu, Bin, et al.
Publicado: (2021)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients
por: Huang, Linna, et al.
Publicado: (2021)

Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor
por: Barhoumi, Tlili, et al.
Publicado: (2023)

Redox-sensitive calcium/calmodulin-dependent protein kinase IIα in angiotensin II intra-neuronal signaling and hypertension
por: Basu, Urmi, et al.
Publicado: (2019)

Angiotensin II during Experimentally Simulated Central Hypovolemia
por: Jensen, Theo Walther, et al.
Publicado: (2016)

Nitric oxide impacts on angiotensin AT2 receptor modulation of high-pressure baroreflex control of renal sympathetic nerve activity in anaesthetized rats
por: Abdulla, M H, et al.
Publicado: (2014)

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

Interlinking Antecedent Malaria and Hypertension Through Angiotensin II in India
por: Tiwari, Aparna, et al.
Publicado: (2021)

Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion
por: Li, Kangbo, et al.
Publicado: (2023)

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study
por: Williams, Bryan, et al.
Publicado: (2014)

Sustained Downregulation of Vascular Smooth Muscle Acta2 After Transient Angiotensin II Infusion: A New Model of “Vascular Memory”
por: Pothen, Lucie, et al.
Publicado: (2022)

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019
por: van Lier, Dirk, et al.
Publicado: (2022)

Bradycardia unresponded to atropin testing was successfully treated with therapeutic plasma exchange in a patient with severe COVID-19 complicated by Guillain-Barré syndrome: A case report
por: Duong-Quy, Sy, et al.
Publicado: (2023)

Effect of optimized new Shengmai powder on exercise tolerance in rats with heart failure by regulating the ubiquitin-proteasome signaling pathway
por: Wang, Shuai, et al.
Publicado: (2023)

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment
por: Pandya, Nischal R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_44jnoirq8hppeln4hikuiaug0k